Landscapes / Targets
IL-13
5 drugs act on IL-13, in 21 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs5
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
Eli Lilly · Public LLY |
Approved | 25 Apr 2027Phase 3 trial completes | ||
| How it works | An antibody | ||||
| Next date | 25 Apr 2027 · Phase 3 trial completes | ||||
| Also tested for | Atopic Dermatitis, Eczema and 4 more | ||||
| Open drug page | |||||
Monoclonal antibody |
Approved | — | |||
| How it works | An antibody | ||||
| Also tested for | Atopic Dermatitis | ||||
| Open drug page | |||||
Multi-specific immunoglobulin |
Sanofi · Public SNY |
Phase 3 | 21 Jun 2027Phase 2 trial completes | ||
| How it works | An antibody built to latch onto two or more targets at once | ||||
| Next date | 21 Jun 2027 · Phase 2 trial completes | ||||
| Also tested for | Chronic Obstructive Pulmonary Disease, Asthma and 1 more | ||||
| Open drug page | |||||
— |
Phase 2 | Nov 2026soonPhase 2 trial completes | |||
| Next date | Nov 2026 · Phase 2 trial completes | ||||
| Also tested for | Atopic Dermatitis, Asthma | ||||
| Open drug page | |||||
Multi-specific immunoglobulin |
Phase 2 | 17 May 2027Phase 2 trial completes | |||
| How it works | An antibody built to latch onto two or more targets at once | ||||
| Next date | 17 May 2027 · Phase 2 trial completes | ||||
| Also tested for | Atopic Dermatitis, Non-cystic Fibrosis Bronchiectasis and 1 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 5 of 5 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026